Isoforms of the promyelocytic leukemia protein differ in their effects on ND10 organization

Experimental Cell Research

Volumn 307, Issue 1, 2005, Pages 109-117

  Beech, Stephanie J ^a   Lethbridge, Katherine J ^a   Killick, Neil ^a   McGlincy, Nicholas ^a,b   Leppard, Keith N ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

ND10; Nuclear organization; PML; Promyelocytic leukemia

Indexed keywords

ISOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL COUNT; CELL NUCLEUS; CELL SHAPE; CELL SIZE; CELL STRUCTURE; CONTROLLED STUDY; DIPLOIDY; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPRODUCIBILITY;

EID: 19544380887     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.03.012     Document Type: Article

References (30)

1. T.G. Hofmann, and H. Will Body language: the function of PML nuclear bodies in apoptosis regulation Cell Death Differ. 10 2003 1290 1299
2. K.L.B. Borden Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies Mol. Cell. Biol. 22 2002 5259 5269
3. R.D. Everett, P. Lamonte, T. Sternsdorf, R. van Driel, and A. Orr Cell cycle regulation of PML modification and ND10 composition J. Cell Sci. 112 1999 4581 4588
4. G.G. Maul, E. Yu, A.M. Ishov, and A.L. Epstein Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress J. Cell. Biochem. 59 1995 498 513
5. J.A. Dyck, G.G. Maul, W.J. Miller, J.D. Chen, A. Kakizuka, and R.M. Evans A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein Cell 76 1994 333 343
6. M.H.M. Koken, F. Puvion-Dutilleul, M.C. Guillemin, A. Viron, G. Linarescruz, N. Stuurman, L. Dejong, C. Szostecki, F. Calvo, C. Chomienne, L. Degos, E. Puvion, and H. De The The t(1517) translocation alters a nuclear-body in a retinoic acid-reversible fashion EMBO J. 13 1994 1073 1083
7. K. Weis, S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean Retinoic acid regulates aberrant nuclear-localization of PML-RAR-alpha in acute promyelocytic leukemia cells Cell 76 1994 345 356
8. B. Terris, V. Baldin, S. Dubois, C. Degott, J.F. Flejou, D. Henin, and A. Dejean PML nuclear bodies are general targets for inflammation and cell proliferation Cancer Res. 55 1995 1590 1597
9. M. Szendefi, H. Walt, T.B. Krasieva, R. Caduff, K.E. Osann, and V.J. LaMorte Association between promyelocyte protein and small ubiquitin-like modifier protein and the progression of cervical neoplasia Obstet. Gynecol. 102 2003 1269 1277
10. R.D. Everett, and G.G. Maul HSV-1 IE protein Vmw110 causes redistribution of PML EMBO J. 13 1994 5062 5069
11. T. Carvalho, J.S. Seeler, K. Ohman, P. Jordan, U. Pettersson, G. Akusjarvi, M. Carmofonseca, and A. Dejean Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies J. Cell Biol. 131 1995 45 56
12. M.T. Daniel, M. Koken, O. Romagne, S. Barbey, A. Bazarbachi, M. Stadler, M.C. Guillemin, L. Degos, C. Chomienne, and H. de The PML protein expression in hematopoietic and acute promyelocytic leukemia cells Blood 82 1993 1858 1867
13. H. de The, C. Lavau, A. Marcho, C. Chomienne, L. Degos, and A. DeJean The PML-RAR alpha fusion mRNA generated by the t15;17 translocation in promyelocytic leukemia encodes a functionally altered RAR Cell 66 1991 675 684
14. A.D. Goddard, J. Borrow, P.S. Freemont, and E. Solomon Characterization of a zinc finger gene disrupted by the t(15,17) in acute promyelocytic leukemia Science 254 1991 1371 1374
15. A. Kakizuka, W.H. Miller, K. Umesono, R.P. Warrell, S.R. Frankel, V.V.V.S. Murty, E. Dmitrovsky, and R.M. Evans Chromosomal translocation t(15:17) in human acute promyelocytic leukemia fuses RAR-alpha with a novel putative transcription factor PML Cell 66 1991 663 674
16. A.M. Ishov, A.G. Sotnikov, D. Negorev, O.V. Vladimirova, N. Neff, T. Kamitani, E.T.H. Yeh, J.F. Strauss, and G.G. Maul PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1 J. Cell Biol. 147 1999 221 233
17. M. Fagioli, M. Alcalay, P.P. Pandolfi, L. Venturini, A. Mencarelli, A. Simeone, D. Acampora, F. Grignani, and P.G. Pelicci Alternative splicing of PML transcripts predicts expression of several carboxyterminally different protein isoforms Oncogene 7 1992 1083 1091
18. T. Kamitani, K. Kito, H.P. Nguyen, H. Wada, T. Fukuda-Kamitani, and E.T.H. Yeh Identification of three major sentrinization sites in PML J. Biol. Chem. 273 1998 26675 26682
19. S. Muller, M.J. Matunis, and A. DeJean Conjugation of the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus EMBO J. 17 1998 61 70
20. K. Jensen, C. Shiels, and P.S. Freemont PML protein isoforms and the RBCC/TRIM motif Oncogene 20 2001 7223 7233
21. K.N. Leppard, and R.D. Everett The adenovirus type 5 E1b 55K and E4 Orf3 proteins associate in infected cells and affect ND10 components J. Gen. Virol. 80 1999 997 1008
22. O. Bischof, O. Kirsh, M. Pearson, K. Itahana, P.G. Pelicci, and A. Dejean Deconstructing PML-induced premature senescence EMBO J. 21 2002 3358 3369
23. M.H.M. Koken, G. Linarescruz, F. Quignon, A. Viron, M.K. Chelbi-Alix, J. Sobczakthepot, L. Juhlin, L. Degos, F. Calvo, and H. De The The PML growth-suppressor has an altered expression in human oncogenesis Oncogene 10 1995 1315 1324
24. K. Wiesmeijer, C. Molenaar, I. Bekeer, H.J. Tanke, and R.W. Dirks Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not J. Struct. Biol. 140 2002 180 188
25. K.L.B. Borden, M.N. Boddy, J. Lally, N.J. Oreilly, S. Martin, K. Howe, E. Solomon, and P.S. Freemont The solution structure of the ring finger domain from the acute promyelocytic leukemia proto-oncoprotein PML EMBO J. 14 1995 1532 1541
26. K.L.B. Borden, J.M. Lally, S.R. Martin, N.J. Oreilly, E. Solomon, and P.S. Freemont In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML Proc. Natl. Acad. Sci. U. S. A. 93 1996 1601 1606
27. E. Duprez, A.J. Saurin, J.M. Desterro, V. Lallemand-Breitenbach, K. Howe, M.N. Boddy, E. Solomon, H. de The, R.T. Hay, and P.S. Freemont SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation J. Cell Sci. 112 1999 381 393
28. M. Fagioli, M. Alcalay, L. Tomassoni, P.F. Ferrucci, A. Mencarelli, D. Riganelli, F. Grignani, T. Pozzan, I. Nicoletti, F. Grignani, and P.G. Pelicci Cooperation between the RING+B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival Oncogene 16 1998 2905 2913
29. D.L. Black Mechanisms of alternative pre-messenger RNA splicing Annu. Rev. Biochem. 72 2003 291 336
30. F. Quignon, F. DeBels, M. Koken, J. Feunteun, J.C. Ameisen, and H. deThe PML induces a novel caspase-independent death process Nat. Genet. 20 1998 259 265